NGS Cancer Panels
Fixed and custom research panels targeting known variants for cancer-related genes
Cancer Panels
Targeted panels tailored for cancer research
Illumina offers a broad portfolio of cancer-focused next-generation sequencing (NGS) panels across multiple application areas. These products have been optimized with clinical cancer research in mind. Achieve sequence-ready libraries from as little as 1 ng of high-quality input or 10 ng formalin-fixed paraffin-embedded (FFPE) sample using efficient, optimized assays and integrated sequencing and bioinformatics. Our comprehensive offering includes both fixed panels and custom options.
Key Use
Method
Specialized Sample Types
Cancer Type
Technology
Product Categories
Variant class
Instruments
Related Solutions
Cancer Sequencing Methods
NGS-based cancer sequencing methods provide more information in less time compared to single-gene and array-based approaches.
Cancer Research Applications
Learn about NGS-based cancer research applications that are driving advances in cancer detection, characterization, and analysis.
Cancer Genomics Research
Our sequencing and microarray technologies support a broad range of cancer genomics research applications, from DNA to RNA analysis, epigenetics, and more.